Jeil Pharma Holdings Inc
KRX:002620

Watchlist Manager
Jeil Pharma Holdings Inc Logo
Jeil Pharma Holdings Inc
KRX:002620
Watchlist
Price: 8 180 KRW 2% Market Closed
Market Cap: 130.6B KRW

Intrinsic Value

The intrinsic value of one Jeil Pharma Holdings Inc stock under the Base Case scenario is hidden KRW. Compared to the current market price of 8 180 KRW, Jeil Pharma Holdings Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Jeil Pharma Holdings Inc Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Jeil Pharma Holdings Inc

Intrinsic Value History
Dive into the past to invest in the future

Jeil Pharma Holdings Inc looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if Jeil Pharma Holdings Inc is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Jeil Pharma Holdings Inc?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Jeil Pharma Holdings Inc valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Jeil Pharma Holdings Inc.

Explain Valuation
Compare Jeil Pharma Holdings Inc to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Jeil Pharma Holdings Inc?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Jeil Pharma Holdings Inc

Current Assets 367.8B
Cash & Short-Term Investments 71.2B
Receivables 176.6B
Other Current Assets 120B
Non-Current Assets 478.3B
Long-Term Investments 211.9B
PP&E 241.6B
Intangibles 15.9B
Other Non-Current Assets 8.9B
Current Liabilities 323.7B
Accounts Payable 97.5B
Accrued Liabilities 395.3m
Short-Term Debt 151.7B
Other Current Liabilities 74.1B
Non-Current Liabilities 212B
Long-Term Debt 17.4B
Other Non-Current Liabilities 194.6B
Efficiency

Free Cash Flow Analysis
Jeil Pharma Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Jeil Pharma Holdings Inc

Revenue
735.8B KRW
Cost of Revenue
-512B KRW
Gross Profit
223.8B KRW
Operating Expenses
-254.3B KRW
Operating Income
-30.5B KRW
Other Expenses
-4.7B KRW
Net Income
-35.2B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Jeil Pharma Holdings Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Healthy Gross Margin
Sustainable 3Y Average Gross Margin
Gross Margin is Increasing
ROIC is Increasing
hidden
Profitability
Score

Jeil Pharma Holdings Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Jeil Pharma Holdings Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
hidden
Solvency
Score

Jeil Pharma Holdings Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Jeil Pharma Holdings Inc

There are no price targets for Jeil Pharma Holdings Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Jeil Pharma Holdings Inc is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Jeil Pharma Holdings Inc stock?

The intrinsic value of one Jeil Pharma Holdings Inc stock under the Base Case scenario is hidden KRW.

Is Jeil Pharma Holdings Inc stock undervalued or overvalued?

Compared to the current market price of 8 180 KRW, Jeil Pharma Holdings Inc is hidden .

Back to Top